Company Profile

Health Fidelity Inc
Profile last edited on: 4/24/2017      CAGE: 6LX23      UEI: K9PMHZ1KQTT9

Business Identifier: Identification, assessment and quantification of risk patient populations
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

210 South B Street
San Mateo, CA 94401
   (650) 727-3300
Location: Single
Congr. District: 15
County: San Mateo

Public Profile

Health Fidelity, Inc. engages in the development and commercialization of a clinical natural language processing (NLP) platform that enables medical practitioners and administrators to make use of the wealth of currently unusable medical information they collect. The company's Fidelity Platform enables automated extraction of usable data from unstructured clinical text to SNOMED, a clinical ontology. Its platform allows application companies to partner with a platform NLP company to address healthcare trends; CMOs, CMIOs, and CIOs to broader insight into previously unusable unstructured content; doctors to automate current manual coding required by the physician results; and patients to utilize clinical chart for analytics. Health Fidelity’s REVEAL platform is advanced, proven clinical NLP technology. The product incorporates the renowned Medical Language Encoding and Extraction (MedLEE) system from Columbia University, encompassing more than 20 years of content and logic development, supported by the earliest patents in the space, referenced more than any other healthcare NLP engine in the scientific literature, and validated by hundreds of successful cutting edge projects including outcomes measurement, quality improvement, readmission reduction, and adverse events detection. Next generation technologies incorporated within REVEAL include clinical content modeling, schema support, and web services deployment, representing the vanguard in clinical NLP.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 2 NSF $555,687
Project Title: Development of Cohort Identification Tool
2012 1 NIH $150,000
Project Title: Contextual Asr to Support Ehr Adoption

Key People / Management

  Dan Riskin -- Former CEO and Co-Founder

  Steve Whitehurst -- CEO

  Yan Chow -- Found

  Anand Shroff -- Chief Technology and Product Officer and Co-Founder

  Raj Tiwari